A synthetic peptide for use as a blocking control in assays to test for specificity of WNT16 antibody, Alternative Names: WNT16 control peptide, WNT16 antibody Blocking Peptide, Anti-WNT16 Blocking Peptide, Wingless-Type Mmtv Integration Site Family Member 16 Blocking Peptide, WNT16, WNT-16, WNT 16, WNT-16 Blocking Peptide, WNT 16 Blocking Peptide
WNT16
Reaktivität: Human, Affe, Kaninchen
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
WNT16
(Wingless-Type MMTV Integration Site Family, Member 16 (WNT16))
Synonyme
zgc:77293 Peptide, E130309I19Rik Peptide, Wnt family member 16 Peptide, wingless-type MMTV integration site family, member 16 Peptide, WNT16 Peptide, wnt16 Peptide, Wnt16 Peptide
Hintergrund
WNT proteins are secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. WNT16 contains two transcript variants diverging at the 5' termini. These two variants are proposed to be the products of separate promoters and not to be splice variants from a single promoter. They are differentially expressed in normal tissues, one of which (variant 2) is expressed at significant levels only in the pancreas, whereas another one (variant 1) is expressed more ubiquitously with highest levels in adult kidney, placenta, brain, heart, and spleen.